Clinical trial
Prospective Evaluation of Clinical Safety of Combining Metformin With Anticancer Chemotherapy
NCT01442870 is registered in ClinicalTrials.gov with Tufts Medical Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Prospective Evaluation of Clinical Safety of Combining Metformin With Anticancer Chemotherapy
- Lead sponsor
- Tufts Medical Center
- Phase
- Phase 1
- Overall status
- Completed
- Start date
- September 30, 2011
- Completion date
- November 30, 2014
- Enrollment
- 105 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
cancer